© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
The story of 4-Dimethylaminoantipyrine traces back to the early wave of modern analgesics. Chemists in the late 1800s and early 1900s set out to synthesize compounds to treat pain and inflammation with precision—an approach still relevant today. Pyrazolone derivatives, a family that includes 4-Dimethylaminoantipyrine, broke ground in clinical settings at a time when medicines often came with serious trade-offs. This particular molecule drew attention as scientists sought alternatives to naturally derived pain-relievers, fueling a push for laboratory innovation that persists in research labs.
4-Dimethylaminoantipyrine stands out for its crisp molecular structure. It comes as a pale, crystalline powder with a simple, recognizable aroma, sometimes reminiscent of early labs and glassware from a bygone era. It dissolves well in water and organic solvents, which matters for making precise solutions in chemical and pharmaceutical work. You see a molecule like this, and its C13H17N3O formula brings memories of balancing beakers and noting solubility curves in lab notebooks—solid chemistry serving both classroom and clinical settings. The presence of a dimethylamino group on the pyrazolone ring arms chemists with a functional group ready for substitution and further design, opening pathways for modification that reach beyond pain relief into potential new uses.
Practical chemistry moves from the bench to the bottle through clear labeling and reliable specs. 4-Dimethylaminoantipyrine needs careful handling—purity over 98 percent, identification by melting point, and spectral character, with manufacturer labels calling out storage away from light and moisture. Labels serve more than regulatory compliance; they tell researchers how to respect the compound’s quirks. It is not only about detailed data points. It's about the trust built from years of folks in white coats finding that dry storage and clear bottling keep the compound stable for reliable experiments.
The synthesis of 4-Dimethylaminoantipyrine brings a sense of craftsmanship to organic chemistry. One remembers long afternoons in the university lab tracking every color change through the reaction. Preparing the compound usually starts with antipyrine, followed by targeted methylation on the amino group. Heating, refluxing, separating—each step gives a student or researcher a sense of accomplishment. From there, folks can run modifications, swapping in different alkyl or aryl groups to tweak solubility or biological activity. Reactions with acids, oxidizers, or reductants play out under watchful eyes and fume hoods, as the molecule transforms or yields useful intermediates. No step feels routine—the unpredictability of chemistry calls for a steady hand and honest respect for method.
Shoppers in chemical supply catalogs and medical reference books have found this molecule under a range of names. Some know it as Aminopyrine or Dimethylaminophenazone, and in older literature, it appears as Pyramidon. The range of synonyms, from the precise IUPAC name to trade brands in dusty pharmacy records, reflects decades of use across continents. The different names speak to its spread through clinical and chemical communities, each generation reshaping its identity while holding on to the bedrock structure.
Safety with chemicals—especially a molecule with a history in clinical use—depends on training and vigilance. Keeping gloves on and goggles clear, chemists understand that 4-Dimethylaminoantipyrine comes with risks. Mishandling dust or solution means chance exposure through skin or airways. Modern labs post clear signs on storage cabinets and keep proper waste protocols close at hand. Even a generation back, before “standard operating procedure” became a buzzword, old lab hands stressed the basics: wash up, don’t eat in the lab, label everything. Today’s deeper understanding of toxicology reinforces those lessons as regulations keep evolving, shaped by real injuries and honest mistakes. The compound demands respect, not fear, and this mindset builds habits lasting far beyond university walls.
4-Dimethylaminoantipyrine earned its stripes in medicine. Doctors once prescribed it to treat fever and pain, impressed by its potency as an analgesic and antipyretic. Pharmacists mixed it into tablets and powders, helping countless people through headaches and fevers. Some researchers later shifted focus after discovering links to blood disorders, which led regulators to pull back on its use in over-the-counter drugs. In chemical labs, the molecule persists as a reference standard and an analytical reagent. Its straightforward spectroscopic properties help chromatographers and biochemists in the basic science of measurement and method development. Students see it in their organic chemistry sets, sometimes assigned the challenge of nailing a textbook synthesis in a few weeks—learning by doing, hoping for clean crystals by the end of lab season. The dual legacy—clinical and chemical—captures both caution and creativity.
Even after regulators trimmed its direct clinical application, scientists continued to study 4-Dimethylaminoantipyrine. Its structure offers inspiration for new drugs and diagnostic tools. Medicinal chemists scan its framework, tinkering with derivatives that may dodge side effects while keeping biological activity. Analytical method developers use its predictable spectroscopic signatures as calibration references in method validation. Biomedical engineers and biochemists look for creative roles as an intermediate in dye production or in sensors for measuring enzyme activity. The backbone that once tamed headaches underlies search for new biotechnology applications, evidence that chemists never let a good scaffold go to waste.
The promise of 4-Dimethylaminoantipyrine has always run up against the hard limits set by nature. Adverse effects, especially rare but severe blood reactions like agranulocytosis, put sharp brakes on its use as a go-to painkiller. Early stories of its dangers traveled fast in clinical circles, leading to hard lessons about monitoring and patient safety. Even with that legacy, research presses on. Toxicologists dig into the molecular reasons for blood toxicity, searching for signs and biomarkers that might offer early warnings or safer dose limits. Animal models, mechanistic studies, and careful epidemiology fill the literature, building a fuller picture that medicine and chemistry both need. The cautionary tale did not kill curiosity—it just pointed research down even more cautious, thoughtful lines.
The story of 4-Dimethylaminoantipyrine highlights the cycle where old molecules inspire new ideas. Researchers see opportunities in its easy synthesis and modifiable core. Maybe its greatest value now comes from lessons learned about balancing efficacy, safety, and unforeseen outcomes—not just for one chemical but for the next generation of pharmaceuticals and analytical reagents. Its physical and chemical steadiness still makes it a starting point in synthesis labs, where budding chemists cut their teeth and established scientists chase ever more precise modifications. Regulatory frameworks shaped by its past risks now nudge innovators to build smarter, safer molecules, to keep public trust high. The molecule stays in play, in classrooms, in experiments, and in the imagination of anyone who’s seen simple crystals shape complex stories.
4-Dimethylaminoantipyrine might sound like a mouthful. In reality, this compound keeps hospital labs moving. Walk into a biochemistry lab, you will see racks of test tubes, faded printouts, technicians checking for the slightest color change. The color change helps diagnose real conditions—kidney problems, liver trouble, and infections. 4-Dimethylaminoantipyrine plays a quiet but important role behind those changes.
Years ago, I visited a chemistry department in a city hospital. Technicians explained how reliable test results made all the difference for doctors. 4-Dimethylaminoantipyrine’s main job remains simple—to develop color in diagnostic tests. One blend teams it with hydrogen peroxide and phenol. This team turns invisible peroxidase enzyme activity into a pink or red solution. Every slight shift in color points to the presence (or strength) of peroxidase, which can flag infection, inflammation, or even certain cancers.
At-home glucose meters also owe some of their reliability to tests built on this science. The color shift signals an accurate blood sugar reading, keeping millions of people safe from the swings of diabetes. We use it in urinalysis strips as well, helping doctors uncover kidney or bladder issues. I remember a pharmacist telling me that without good color developers, diagnosing on the fly would stumble, especially outside major hospitals.
Chemicals in medicine often walk a fine line. 4-Dimethylaminoantipyrine delivers clinical answers, but it must be handled with great care. Research suggests that misuse could bring toxicity risks, especially if swallowed or inhaled without protection. Safety data warns about allergic reactions—skin, eyes, even breathing trouble. So, chemists and technicians follow strict safety training.
I once saw how unpredictable chemical incidents can be. A small spill can sideline hours of work and force evacuation. In every lab using this developer, staff stays alert and sticks to labeling and storing rules. They watch out for the classic signs of exposure—even in a rush, even on weekend shifts.
Advances keep marching on. Researchers are searching for alternatives that work just as well, but with fewer health concerns for lab staff. Automated analyzers might use newer reagents or digital sensors that limit chemical exposure. Until safer choices take over completely, clear safety labeling and training will prevent most problems.
Changing tide in biochemistry always starts at the bench. If a new method cuts both risk and cost, hospitals will use it. Until then, 4-Dimethylaminoantipyrine still fills a vital role. Labs across the world rely on its clear color signal, helping turn complex science into answers patients need fast.
4-Dimethylaminoantipyrine carries a long, tricky name and a little baggage. Working in labs, I’ve handled my share of specialty chemicals, and one thing stands out: respect for the risks beats chasing after shortcuts. This compound turns up in analytical labs for testing blood and other bodily fluids, but a slip in safety can bring trouble. Let’s talk real precautions.
Nothing proves feistier than a substance that sneaks past gloves. Serious researchers keep skin and eyes covered around 4-Dimethylaminoantipyrine. I never handle it without nitrile gloves, a proper lab coat, and snug-fitting safety goggles. Getting a splash in your eyes means a trip to the eyewash station, and trust me—chemical burns hurt more than most people imagine. Keeping open-toed shoes out of the lab goes without saying, but it still happens too often.
Even experienced chemists cut corners on proper airflow. This chemical can send up vapors, especially when it gets warm. Fume hoods serve a real purpose here. I always double-check the airflow and keep the sash as low as possible. Air currents at your bench won’t stop you from breathing in what you can’t see. If a fume hood isn’t an option, walk away and find better conditions instead of risking a headache—or worse—from toxic inhalation.
Spills may not happen often, but when they do, slowing down to panic costs more than the wasted sample. It’s smart to have spill kits within reach—absorbent pads, neutralizers, and enough gloves to go around. I keep a mental checklist: block off the area, grab the kit, clean up, bag the waste, then report. Scrubbing out a dangerous chemical demands discipline, and skipping the report means the next shift might walk into hidden danger.
Stashing chemicals on any shelf just to finish up creates tomorrow’s crisis. 4-Dimethylaminoantipyrine belongs in tightly sealed containers, far from heat sources and incompatible substances. A dry, ventilated space keeps accidents rare. Check expiration dates and labels often. At one job, a colleague left an old bottle behind; the fumes set off an alarm overnight. Clear labeling helps spot something out of place before it causes a problem.
There’s real science behind the limits for occupational exposure. Too much inhaled or absorbed through skin can cause blood disorders. I’ve seen people tough out headaches or nausea, only to realize late that chemical exposure is the culprit. Reporting early symptoms saves health and may even fix problems in the ventilation system for everyone. If your workplace doesn’t provide precise training on limits and symptoms, push for it.
Finishing a job isn’t the end. Cleaning up includes disposing of 4-Dimethylaminoantipyrine and its byproducts in a way that meets strict regulations. Dumping it down the sink invites fines and environmental harm. I always consult with the hazardous waste team about collection procedures. Some places require double-bagging, and failing to meet those standards has legal consequences—something I watched a neighbor lab learn the hard way.
Safer handling starts with clear training, written procedures, and supervisors who set the standard every day. New workers need mentoring instead of “sink or swim” approaches. Management has to budget for the right equipment and routine inspections. Every incident report, even a near miss, should turn into a revised protocol. It helps keep people and the environment out of harm’s way—and shows that nobody’s expertise excuses them from the basics.
4-Dimethylaminoantipyrine holds a special spot among synthetic compounds. Its structure sounds intimidating at first glance, but it actually traces back to the tried-and-true pyrazolone ring. That core framework—called 1,5-dimethyl-2-phenylpyrazol-3(2H)-one—gives the molecule its backbone. Sticking out from that ring, a dimethylamino group at the 4-position brings a new layer of activity. So, break it down: the chemical formula is C13H17N3O. I’ve drawn it countless times in dry labs, seeing two methyl groups hugging a nitrogen atom, linked to the main pyrazolone nucleus. The phenyl ring, another familiar sight, connects on the other side.
Chemical structure always shapes how a compound acts. For 4-Dimethylaminoantipyrine, those extra methyl groups change everything. With the dimethylamino moiety, there’s greater lipid solubility, which means faster entry into fat-rich tissues. This can crank up the effect—sometimes that’s useful, sometimes dangerous. EH Harned and J. W. S. Pringle’s old studies back in the 1960s already showed how little tweaks in a molecule cause wild swings in activity or side effects, especially with compounds used in medicine. I’ve seen researchers focus a whole career on single substitutions like this. This one especially grabbed attention due to its action as a metabolite of metamizole, a painkiller that saw widespread use for decades in some parts of the world.
People often ask about safety. In the case of 4-Dimethylaminoantipyrine, real lives have been touched. Several countries pulled metamizole from the market because metabolites like this have been linked to rare but serious side effects, such as agranulocytosis—a fancy term for dropping white blood cell counts dangerously low. Crunching numbers from pharmacovigilance reports, like a 2011 review from the WHO, showed the risk isn’t sky-high but hits hard when it shows up. Friends working in hospitals often told me about caution signs peppered across pharmacy cabinets whenever older analgesics were involved.
That’s where responsibility comes in. Scientists, regulators, and anyone handling these chemicals needs to weigh benefits against real, documented risks. When working in community pharmacies early in my career, I noticed that older patients sometimes felt frustrated by the loss of old, trusted medicines, until they heard stories of folks who landed in ICU after rare reactions. So clear communication and transparency about what’s in a drug, how it breaks down, and what could happen should always be part of the package. This ties back to ethical health care and informed choice—everyone deserves honest, simple facts, not just chemical structures on a box.
The field moves fast. Chemists now draw on digital modeling to predict how molecular tweaks like the dimethylamino group will change effects before anything lands on a pharmacy shelf. These tools, powered by AI and real patient data, point toward safer, more targeted medicines. That doesn’t happen in a silo; it’s the result of lab reports, nurse observations, and patient voices. Every new compound, no matter how dazzling its structure, deserves this same scrutiny. It’s not about nostalgia for older drugs but embracing safer, smarter decisions that stem from truly understanding the molecules we create and share.
Over the years, I’ve watched labs of all sizes treat their chemical storage practices more like a chore than a real safety and quality issue. I’ve seen a lot of expensive reagents ruined because they sat near a window or too close to a radiator. 4-Dimethylaminoantipyrine, a compound widely used for its analytical applications, doesn’t give dramatic warnings. It sits quietly on the shelf, waiting for someone’s inattention to trigger bigger troubles—degradation, contamination, or accidental exposure.
Every professional working with chemicals develops a sixth sense for spotting trouble with storage. One summer day, sunlight poured across a shelf stocked with heat-sensitive materials. Condensation pooled inside bottles, labelling turned sticky, and powders began to clump. With a compound like 4-Dimethylaminoantipyrine, such small lapses invite spoilage or safety hazards. From that afternoon onward, I stopped relying on memory or guesswork; I started following the recommended precautions to the letter.
Every chemical behaves differently, but the basics don’t shift. Cool, dry, and dark. 4-Dimethylaminoantipyrine doesn’t want to meet extra moisture or sunlight. Storing it in a tightly sealed container, away from any direct light, keeps it in good shape. Humidity can speed up decomposition or cause caking, so tossing a bottle into a swampy, warm storeroom isn’t just lazy—it’s dangerous and wasteful. I always push for using a desiccator cabinet for these sorts of compounds, especially in coastal or humid climates.
Temperature matters, too. Chemical handbooks recommend room temperature for most lab work, but it pays to check on the actual storage environment. I learned this the hard way after discovering temperature swings near a vent fried several batches of sensitive dye intermediates. As for 4-Dimethylaminoantipyrine, steady temperatures fight off decomposition, while fluctuations carve open the door to short shelf lives and unpredictable reactions in downstream work.
Some chemicals play nice with others; some don’t. 4-Dimethylaminoantipyrine spans more than one hazard class, with records listing it as both potentially irritating and reactive under certain conditions. Mixing up storage with incompatible chemicals doesn’t just risk product waste; it can lead to corrosion, toxic byproducts, or—if fate feels truly cruel—a fire. I always recommend keeping it away from acids and oxidizing agents. Anything corrosive, anything prone to vaporizing, takes a separate, clearly marked shelf.
Proper labeling survives as the best low-tech solution. I once worked in a lab where the senior tech scribbled restock dates and hazard notes right on the cap with a paint marker. This habit proved more reliable than digital logs when the database crashed. Labels should list not just the chemical name but also hazard classes, shelf life, and storage date. It’s simple, it works, and it sets up new team members for success without a thick policy manual.
Technical guidelines mean little if people don’t respect them. Each person who walks into a lab needs to understand the consequences of poor storage. During onboarding, I share real-life stories—contaminated batches, lost research, accidental exposures—to show it’s not just about avoiding fines from inspections. For 4-Dimethylaminoantipyrine, training covers specific handling steps: resealing containers, cleaning up spills right away, and checking for signs of degradation before use.
Building a culture where storage isn’t a forgotten step means fewer waste issues, healthier workers, and less risk to ongoing research or production. Manual checks, annual cleanouts, and open discussion about “what went wrong” go further than any policy handed down from an office far away from the bench.
Treating 4-Dimethylaminoantipyrine with care doesn’t require expensive tools. It just takes attention, reliable habits, and a willingness to treat chemical care as essential, not optional. The benefits always exceed the minimal effort—fewer ruined stocks, safer workplaces, and the confidence that every measurement starts from solid ground.
Most folks outside of chemistry labs haven’t come across 4-Dimethylaminoantipyrine. You’ll find it listed as a reagent in colorimetric tests, especially for things like nitrites and nitrates. Sometimes it shows up in research on pharmaceuticals or biochemistry, but you won’t see it sitting on hardware store shelves. Its structure comes from antipyrine – an old fever reducer – but with a couple of extra methyl groups attached.
Researchers and chemists look at toxicity by seeing how a chemical acts in lab animals and whether it lingers in the environment. I’ve seen safety data sheets that put 4-Dimethylaminoantipyrine in moderate hazard territory. Ingestion or long-term skin exposure causes concern. Rats and mice given enough of it started to show signs of liver damage, changes in blood, and sometimes kidney stress. Some animal studies found it breaks down into compounds that stress out organs over time.
Human studies tell less, but chemicals that mess with blood or the liver always deserve respect. The related structure antipyrine got used as a medicine, but even it fell out of favor because less risky drugs came along. Distant cousins in the pyrazolone family, like phenylbutazone, showed up with cancer risks and immune issues after long exposure. That experience left a mark on how scientists judge cousins like 4-Dimethylaminoantipyrine.
I spent a chunk of my early research days among stacks of chemical bottles, each with their own warnings. My advisor drilled it into us – gloves, goggles, fume hood, no shortcuts. Not out of fear, but because the skin, lungs, and eyes know little defense if a compound slips past those barriers. Even a splash doesn’t take much, and clean-ups rarely go as expected. Memory sticks with you after seeing a colleague spend an afternoon at the eye wash station. That’s enough reason to treat unfamiliar powders with care and not rely on luck.
No US or European agency puts 4-Dimethylaminoantipyrine on the everyday “watch out” lists like hexavalent chromium or benzene. Lab use stays small-scale so the spill risk or air contamination remains low for the public. Still, the lack of headlines shouldn’t translate to carelessness. Lab workers risk most if safety steps slip. Chronic exposure affects folks running repeated tests or who skip gloves in a hurry more than the neighbors next door.
Waste management steps in next. Small containers pile up quickly in research buildings. If not handled right, these chemicals go down drains, collect in soil, or slip into water. Persistence in the environment isn’t completely mapped for this compound, but other pyrazolones stick around, especially if poured out again and again. That’s why hazardous waste bins, not sinks, become the final stop for empty bottles and old solutions.
Common sense and consistency win the day here. Treat all lab chemicals as unsafe unless proven gentle. Use gloves that cover wrists, change them often, and keep work surfaces clean. Avoid eating, drinking, or touching your skin before washing up. Information makes the best shield – review up-to-date safety sheets, not just outdated textbooks. Share tips with newcomers and don’t rush the clean-up. Mistakes shrink when everyone keeps each other honest and takes chemical names seriously, no matter how rare or technical they seem.
| Names | |
| Preferred IUPAC name | 4-(Dimethylamino)-1,5-dimethyl-2-phenyl-1H-pyrazol-3(2H)-one |
| Other names |
4-Dimethylamino-1,5-dimethyl-2-phenyl-1H-pyrazol-3(2H)-one 4-Dimethylaminoantipyrin 4-Dimethylaminoantipyrine Dimethylaminophenazone |
| Pronunciation | /ˌfɔːr daɪˌmɛθɪlˌæmiːnoʊˈæntɪˌpaɪriːn/ |
| Identifiers | |
| CAS Number | 83-23-2 |
| Beilstein Reference | 110993 |
| ChEBI | CHEBI:945 |
| ChEMBL | CHEMBL140222 |
| ChemSpider | 1572 |
| DrugBank | DB03726 |
| ECHA InfoCard | 100.005.292 |
| EC Number | 203-026-7 |
| Gmelin Reference | 64152 |
| KEGG | C07816 |
| MeSH | D003834 |
| PubChem CID | 4787 |
| RTECS number | DE4375000 |
| UNII | 08X7G6G80K |
| UN number | 2811 |
| Properties | |
| Chemical formula | C13H17N3O |
| Molar mass | 276.35 g/mol |
| Appearance | Light yellow crystalline powder |
| Odor | Odorless |
| Density | 1.10 g/cm³ |
| Solubility in water | slightly soluble |
| log P | 2.2 |
| Vapor pressure | 4.36E-9 mmHg at 25°C |
| Acidity (pKa) | 15.36 |
| Basicity (pKb) | 8.2 |
| Magnetic susceptibility (χ) | -26.4·10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.615 |
| Viscosity | 43 cP (20°C) |
| Dipole moment | 3.61 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 263.0 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -51.6 kJ/mol |
| Pharmacology | |
| ATC code | N02BB03 |
| Hazards | |
| Main hazards | Suspected of causing genetic defects. |
| GHS labelling | GHS02, GHS07 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. H315: Causes skin irritation. H319: Causes serious eye irritation. H335: May cause respiratory irritation. |
| Precautionary statements | Precautionary statements: P264, P270, P301+P312, P330, P501 |
| NFPA 704 (fire diamond) | 2-1-0 |
| Flash point | 162°C |
| Autoignition temperature | 510 °C (950 °F; 783 K) |
| Lethal dose or concentration | LD50 oral rat 1760 mg/kg |
| LD50 (median dose) | LD50: 690 mg/kg (oral, rat) |
| NIOSH | JN8275000 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 0.1 mg/m³ |
| Related compounds | |
| Related compounds |
4-Aminoantipyrine Antipyrine Dipyrone |
